Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Death, Sudden, Cardiac D016757 12 associated lipids
Carotid Stenosis D016893 15 associated lipids
beta-Thalassemia D017086 5 associated lipids
Hypertrophy, Left Ventricular D017379 12 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Osteoblastoma D018215 1 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Sepsis D018805 11 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Young JM et al. Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and -2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production. 1996 Inflamm. Res. pmid:8737748
Laffi G et al. Defective aggregation in cirrhosis is independent of in vivo platelet activation. 1996 J. Hepatol. pmid:8738730
Yang JM et al. Sodium nonivamide acetate: a non-pungently antinociceptive capsaicin derivative with unusual anti-inflammatory properties. 1996 Gen. Pharmacol. pmid:8742512
Yoshida T et al. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904. 1996 Lupus pmid:8743126
Mathie RT et al. The haemodynamic effects of the thromboxane A2 receptor antagonist GR32191B during cardiopulmonary bypass in the dog. 1995 Perfusion pmid:8747897
Yokoyama I et al. Liberation of vasoactive substances and its prevention with thromboxane A2 synthase inhibitor in pig liver transplantation. 1996 Transpl. Int. pmid:8748415
Gu YJ et al. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. 1996 J. Thorac. Cardiovasc. Surg. pmid:8751518
Mito Y [Thromboxane B2 (TXB2)]. 1995 Nippon Rinsho pmid:8753342
Janabi N et al. Endogenous nitric oxide activates prostaglandin F2 alpha production in human microglial cells but not in astrocytes: a study of interactions between eicosanoids, nitric oxide, and superoxide anion (O2-) regulatory pathways. 1996 J. Immunol. pmid:8757337
Hibi S et al. Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase. 1996 J. Med. Chem. pmid:8759636
Fimognari FL et al. Associated daily biosynthesis of cortisol and thromboxane A2: a preliminary report. 1996 J. Lab. Clin. Med. pmid:8759943
Yan GT et al. [Tumor necrosis factor induced enhancement of neutrophil chemotaxis and adhesion through mediating of phospholipase A2 activation]. 1995 Sheng Li Xue Bao pmid:8762444
Zhang M et al. [Reduction of incidence of ischemia-reperfusion induced ventricular fibrillation by captopril]. 1995 Sheng Li Xue Bao pmid:8762446
Xiao J et al. [Effects of platelet activating factor and platelet activating factor receptor antagonist on spinal cord blood flow after spinal cord injury]. 1995 Zhonghua Wai Ke Za Zhi pmid:8762548
Kuroiwa M et al. Effects of granulocyte colony-stimulating factor on the hemostatic system in healthy volunteers. 1996 Int. J. Hematol. pmid:8762814
Fuse I et al. Vascular thromboxane formation in hemostasis mechanism: correlation between bleeding time and vascular TXB2 in a patient with congenital platelet cyclo-oxygenase deficiency. 1996 Int. J. Hematol. pmid:8762815
Izaki S et al. Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation. 1996 Br. J. Dermatol. pmid:8763425
Fleisch JH et al. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor. 1996 J. Pharmacol. Exp. Ther. pmid:8764358
Hrboticky N et al. Linoleic acid esterified in low density lipoprotein serves as substrate for increased arachidonic acid synthesis in differentiating monocytic cells. 1996 Biochim. Biophys. Acta pmid:8765140
Qiu BS et al. Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. 1996 Dig. Dis. Sci. pmid:8769290
Shirabe K et al. Inhibition of thromboxane A2 activity during warm ischemia of the liver. 1996 J. Surg. Res. pmid:8769950
Abernathy VJ et al. C-reactive protein inhibits increased pulmonary vascular permeability induced by fMLP in isolated rabbit lungs. 1996 Am. J. Physiol. pmid:8770090
Closa D et al. Hepatic involvement in pancreatitis-induced lung damage. 1996 Am. J. Physiol. pmid:8772495
Mehta PJ et al. More uses of known drugs. 1995 J Assoc Physicians India pmid:8773057
Madan ZM and Sainani GS Effect of aspirin treatment on plasma levels of keto PGF 1 alpha and thromboxane B2. 1995 J Assoc Physicians India pmid:8773058
Quoc KP and Pascaud M Effects of dietary gamma-linolenic acid on the tissue phospholipid fatty acid composition and the synthesis of eicosanoids in rats. 1996 Ann. Nutr. Metab. pmid:8773734
Nabe T et al. Sephadex G-200-induced eosinophil infiltration into airways in non-sensitized and sensitized guinea pigs, and responsiveness of the cells to stimuli in vitro. 1996 Jpn. J. Pharmacol. pmid:8774762
Gennaro M et al. Perfluorocarbon emulsion prevents eicoasanoid release in skeletal muscle ischemia and reperfusion. 1996 Cardiovasc Surg pmid:8782946
Uhlig S et al. Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin. 1996 Mol. Med. pmid:8784790
Cuzzolin L et al. Effect of single and repeated doses of a new nitroderivative of acetylsalicylic acid on platelet TXA2 production in rats. 1996 Life Sci. pmid:8786689
Zheng NX et al. Pharmacokinetic and pharmacodynamic studies of a thromboxane synthetase inhibitor, ozagrel, in rabbits. 1995 Biol. Pharm. Bull. pmid:8787798
Bell SJ et al. Dietary fish oil and cytokine and eicosanoid production during human immunodeficiency virus infection. 1996 Jan-Feb JPEN J Parenter Enteral Nutr pmid:8788262
Raptopoulos D et al. The effect of xylazine on plasma thromboxane B2 concentration in sheep. 1995 J. Vet. Pharmacol. Ther. pmid:8789696
Vaskonen T et al. Interrelationships between salt and fish oil in stroke-prone spontaneously hypertensive rat. 1996 Blood Press. pmid:8790929
Aïssa J et al. Biochemical and cellular effects of heparin-protamine injection in rabbits are partially inhibited by a PAF-acether receptor antagonist. 1996 Eur. J. Pharmacol. pmid:8791000
Collins CE et al. Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. 1996 Aliment. Pharmacol. Ther. pmid:8791957
Eriksson M et al. Beneficial effects of pre-treatment with vitamin A on cardiac and pulmonary functions in endotoxaemic pigs. 1996 Acta Anaesthesiol Scand pmid:8792882
Uematsu T et al. Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers. 1996 J. Pharm. Pharmacol. pmid:8794987
Ko FN et al. Mechanism of action of p-chlorobiphenyl on the inhibition of platelet aggregation. 1996 J. Pharm. Pharmacol. pmid:8794990
Sakurai S et al. Synthesis of [[(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives containing pyridyl or imidazolyl groups and their thromboxane A2 receptor antagonistic and thromboxane A2 synthase inhibitory activities. 1996 Chem. Pharm. Bull. pmid:8795270
Fox GA et al. Cyclooxygenase inhibition and vascular reactivity in a rat model of hyperdynamic sepsis. 1996 J. Cardiovasc. Pharmacol. pmid:8797133
Morrow JD et al. Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo. 1996 J. Biol. Chem. pmid:8798513
Lewy RI et al. Intravenous heparin initiates in-vivo synthesis and release of thromboxane in angina pectoris. 1979 Lancet pmid:87990
Fekkes D et al. Eicosanoid and amino acid metabolism in transient acute psychoses with psychedelic symptoms. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8804122
Feng J et al. Beneficial effects of iloprost cardioplegia in ischemic arrest in isolated working rat heart. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8804125
González ET et al. Prostanoid modulation of glucose transport in isolated diabetic rat uterus. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8804128
Giulian D et al. Activated microglia are the principal glial source of thromboxane in the central nervous system. 1996 Neurochem. Int. pmid:8808790
Zhen ZY et al. Experimental study on microthrombi and myocardial injuries. 1996 Microvasc. Res. pmid:8812763
Pace-Asciak CR et al. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. 1996 Clin. Chim. Acta pmid:8814965
Yoshida SH et al. Dietary Juniperis virginiensis seed oil decreased pentobarbital-associated mortalities among DBA/1 mice treated with collagen-adjuvant emulsions. 1996 J Lipid Mediat Cell Signal pmid:8816989
Landoni MF et al. Pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. 1996 Res. Vet. Sci. pmid:8819190
Galbraith EA and McKellar QA Protein binding and in vitro serum thromboxane B2 inhibition by flunixin meglumine and meclofenamic acid in dog, goat and horse blood. 1996 Res. Vet. Sci. pmid:8819199
Davì G et al. Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus. 1996 Thromb. Haemost. pmid:8819248
Wagner RS et al. Activation of thromboxane A2 receptors alters lipopolysaccharide-induced adherence of THP-1 cells. 1996 Shock pmid:8821102
Meenan J et al. Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis. 1996 Eur J Gastroenterol Hepatol pmid:8823572
Watanabe M et al. [Changes in platelet sensitivity to thromboxane A2 in pediatric patients with nephrotic syndrome]. 1996 Nihon Jinzo Gakkai Shi pmid:8828355
Mitten LA et al. Phenylbutazone increases right atrial pressure and heart rate of running horses. 1996 J. Appl. Physiol. pmid:8828679
Ishibashi M et al. Identification of 11-dehydro-2,3-dinorthromboxane B3 in human urine based on the mass spectral properties of 11-dehydrothromboxane B3 and related compounds. 1995 Rapid Commun. Mass Spectrom. pmid:8829476
Mizugaki M et al. Microdetermination of 11-dehydrothromboxane B3 in human urine by gas chromatography--selected-ion monitoring using (18O2) analogue as an internal standard. 1995 Rapid Commun. Mass Spectrom. pmid:8829485
Myers SI et al. Long-term resuscitation of hemorrhage/reperfusion injury (H/R) stimulates renal PGE2 release. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8832762
Osiovich H et al. Cardiopulmonary effects of tumor necrosis factor-alpha in the piglet: influence of cyclooxygenase inhibition. 1995 Biol. Neonate pmid:8835089
Meade CJ et al. Pulmonary pharmacology of DT-TX 30 SE, a potent selective combined thromboxane synthetase inhibitor and receptor antagonist, in guinea pigs. 1996 Jpn. J. Pharmacol. pmid:8835638
Fylling AC et al. Kinetic and structural evidence for the identification of 11-hydroxythromboxane B2 dehydrogenase as cytosolic aldehyde dehydrogenase. 1995 Nov-Dec Prostaglandins pmid:8838239
Muller M and Sorrell TC Inhibition of the human platelet cyclooxygenase response by the naturally occurring phenazine derivative, 1-hydroxyphenazine. 1995 Nov-Dec Prostaglandins pmid:8838240
Stichtenoth DO et al. Increased total body synthesis of prostacyclin in rats with adjuvant arthritis. 1995 Nov-Dec Prostaglandins pmid:8838242
Nowak J et al. Thromboxane metabolite excretion in patients with hand-arm vibration syndrome. 1996 Clin Physiol pmid:8842572
Cuiper LL et al. Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2. 1996 J. Appl. Physiol. pmid:8847301
Horiguchi T et al. Pulmonary responses to heparin-protamine complexes: the effects of age and species. 1996 J. Appl. Physiol. pmid:8847332
Gabriel A et al. Influence of prostaglandin E1 on tissue ischemia during surgical repair of the abdominal aorta. 1996 J. Cardiothorac. Vasc. Anesth. pmid:8850397
Chen SJ et al. Antiplatelet and calcium inhibitory properties of eugenol and sodium eugenol acetate. 1996 Gen. Pharmacol. pmid:8853295
Quinn JV et al. Evaluation of enzyme-linked immunosorbent assays for quantitation of eicosanoid mediators of sepsis syndrome. 1996 Shock pmid:8856849
Reale M et al. Human recombinant interleukin-1 beta induces thromboxane A2 release in polymorphonuclear leukocytes, macrophages and platelets: effect of IL-1 receptor antagonist. 1996 Mol. Cell. Biochem. pmid:8858567
Bordia T et al. An evaluation of garlic and onion as antithrombotic agents. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8860105
Pancera P et al. Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8860111
Kanai H et al. Serotonin metabolism in patients undergoing hemodialysis. 1996 Clin. Nephrol. pmid:8861800
Siler-Khodr TM et al. Dose-related action of estradiol on placental prostanoid prediction. 1996 Prostaglandins pmid:8873234
Schaefer WR et al. Urinary excretion of 2,3-dinor-6-keto-PGF1 alpha and 11-dehydro-TXB2 by the gravid spontaneously hypertensive rat. 1996 Prostaglandins pmid:8875634
Mustad V et al. Seasonal variation in parameters related to coronary heart disease risk in young men. 1996 Atherosclerosis pmid:8879440
Selley ML et al. The effect of cholesterol oxidation products on human platelet aggregation. 1996 Thromb. Res. pmid:8885139
Ziyyat A et al. Interactions between nitric oxide and prostanoids in isolated perfused kidneys of the rat. 1996 Br. J. Pharmacol. pmid:8886425
García-Lafuente A et al. Bacterial peptides enhance inflammatory activity in a rat model of colitis. 1996 Digestion pmid:8886582
Carbajal D et al. Possible cytoprotective mechanism in rats of D-002, an anti-ulcerogenic product isolated from beeswax. 1996 J. Pharm. Pharmacol. pmid:8887738
Stiris TA et al. Effects of dexamethasone on retinal and choroidal blood flow during normoxia and hyperoxia in newborn piglets. 1996 Pediatr. Res. pmid:8888288
Myers SI et al. Estrogen increases male rat aortic endothelial cell (RAEC) PGI2 release. 1996 Prostaglandins Leukot. Essent. Fatty Acids pmid:8888351
Chou TC et al. The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation. 1996 Thromb. Res. pmid:8897698
Harada Y et al. Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy. 1996 Prostaglandins pmid:8900441
Karck U et al. PGE2 and PGF2 alpha release by human peritoneal macrophages in endometriosis. 1996 Prostaglandins pmid:8900443
Livingston ER et al. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. 1996 Circulation pmid:8901751
Serebruany VL et al. Mac-1 inhibitor affects certain hemostatic parameters during myocardial stunning in swine. 1996 Pharmacology pmid:8902873
Parnas BL et al. Isolation and structure of leukotriene-A4 hydrolase inhibitor: 8(S)-amino-2(R)-methyl-7-oxononanoic acid produced by Streptomyces diastaticus. 1996 J. Nat. Prod. pmid:8904845
Martin W et al. Respiratory dysfunction and white cell activation following cardiopulmonary bypass: comparison of membrane and bubble oxygenators. 1996 Eur J Cardiothorac Surg pmid:8905281
Montuschi P et al. Tachykinin NK2 receptor antagonists decrease eicosanoid release in lung anaphylaxis. 1996 Eur. J. Pharmacol. pmid:8905345
Nishisho T et al. Experimental and clinical studies of eicosanoids in cerebrospinal fluid after spinal cord injury. 1996 Neurosurgery pmid:8905750
Berdeaux O et al. Effects of a trans isomer of arachidonic acid on rat platelet aggregation and eicosanoid production. 1996 J. Lipid Res. pmid:8906600
Schmid P et al. Passive smoking and platelet thromboxane. 1996 Thromb. Res. pmid:8907294
Chello M et al. Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease. 1996 J. Cardiovasc. Pharmacol. pmid:8907804
Szekacs B et al. Prostacyclin and thromboxane production of rat and cat arterial tissue is altered independently by several vasoactive substances. 1996 Prostaglandins pmid:8908622
Ferrándiz ML et al. Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice. 1996 J. Pharm. Pharmacol. pmid:8910867
Okada M et al. Two mechanisms for platelet-mediated killing of tumour cells: one cyclo-oxygenase dependent and the other nitric oxide dependent. 1996 Immunology pmid:8911154
Shibasaki T et al. Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside. 1996 Am. J. Nephrol. pmid:8919236